Indraprastha Medical Corp has informed that pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSDPoD1/ P/CIR/2023/37 dated 16th March 2023 its RTA- Link Intime India has dispatched the requisite communication letter(s) to the Shareholders of the Company holding shares in physical form requesting them to furnish PAN, KYC and nomination details in prescribed form/formats. The Confirmation of dispatch of said request letters from Link Intime India is enclosed.
The above information is a part of company’s filings submitted to BSE.
